Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.
about
Current medical treatment of estrogen receptor-positive breast cancerCyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoCombination treatment of tamoxifen with risperidone in breast cancerPromoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cellsMesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsLYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancerNodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.Induction of the Estrogenic Marker Calbindn-D₉k by OctamethylcyclotetrasiloxaneNew insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells.Steroid hormone receptors as prognostic markers in breast cancer.Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.Peri-foci adipose-derived stem cells promote chemoresistance in breast cancerMetastatic breast cancer: Endocrine therapy landscape reshaped.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancerTargeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
P2860
Q26795751-826B9A73-DBD5-49EA-B439-3206E72C6747Q27302901-F323010E-2EBC-4A0C-A5E3-780E3225F966Q28539274-B1B92F98-EDA9-4650-A989-29FA5131B894Q34006827-4C5A0C0A-9464-41A8-AFD4-A3AC1E6A5A8CQ34012393-9E7DA168-E432-4491-91DC-9855AD8F85B9Q34022694-DE06200B-90EF-4987-BABD-958303D93298Q34667770-7FD7D81A-F12C-48EC-9C57-E9EBB289F92DQ35000235-7E35091E-30A0-418D-852A-A9DADA990098Q35145443-5883E461-BE40-4387-A4DC-151C7528C328Q36245954-3BE8F96A-DEE3-4534-A593-4CFE9CF1DEA8Q36283422-29D2244D-DDD0-4EB4-8DF1-679321345D62Q36324193-E086DF3A-D4C3-43E8-B178-A0F0E77FF452Q37300127-3ED2551D-0E53-47E9-B5BE-21B8F16258CDQ37705673-B46D087B-D74C-4B33-A265-2A9DA162FE84Q38598704-02D7DEB4-6436-46DA-9ADD-7BF43A239ABFQ38989942-9FDD8BFC-A92A-41F0-AB65-777372D3D8C3Q39185424-5775FCA3-7659-4582-B818-DB250654CE91Q41163628-7D7449C3-28DB-4BBF-BA48-AE9A5C60F82DQ45072397-D82C81AA-4757-487C-8286-1693A74F5AD4Q47135344-A57CCEC5-5D66-4304-A3F1-CC33AC80A952Q48213165-63E026A5-A1ED-4339-92BD-03D56D0700A6Q57107973-077B9D40-BD2E-4226-BE1B-872C281AE953Q58700431-070FE278-6545-4F7A-9B0F-43A3346618EB
P2860
Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@ast
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@en
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@nl
type
label
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@ast
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@en
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@nl
prefLabel
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@ast
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@en
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@nl
P2093
P2860
P1433
P1476
Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.
@en
P2093
Danielle Rivizzigno
Kathryn R Coser
Keiko Shioda
Kristen R McSweeney
Toshi Shioda
Wei-Lan Yeh
P2860
P304
P356
10.1371/JOURNAL.PONE.0060889
P407
P577
2013-04-04T00:00:00Z